Protective Effects of Gemigliptin, a Dipeptidyl Peptidase-4 Inhibitor, against Cisplatin-Induced Nephrotoxicity in Mice

Dipeptidyl peptidase-4 (DPP-4) inhibitors are widely used antihyperglycemic agents for the treatment of type 2 diabetes mellitus. Recently, the pleiotropic actions of DPP-4 inhibitors have drawn much attention. In the present study, we aimed to examine whether gemigliptin, a recently developed DPP-4...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Mediators Inflamm
Egile Nagusiak: Choi, Seung Hee, Leem, Jaechan, Lee, In-Kyu
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Hindawi 2017
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5727799/
https://ncbi.nlm.nih.gov/pubmed/29317794
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2017/4139439
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak